Legal Representation
Attorney
Mary Grace Gallagher
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 26, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 25, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 25, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 22, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 22, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 22, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jul 22, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 24, 2022 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Jan 24, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 24, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 15, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 1, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 20, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 20, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Oct 6, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 6, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 8, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 6, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 6, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 6, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 6, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 11, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 11, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 22, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 9, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 3, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 30, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 30, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 30, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 1, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jan 22, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jan 15, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Dec 30, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 30, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 30, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 19, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 23, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating physical and mental disorders in the nature of epilepsy, convulsions, seizures, nerve damage, pain, chronic pain, inflammation, acne, psoriasis, heart disease, hypertension, coronary artery disease (atherosclerosis), muscle disorders, muscle spasms, bone deficiency, Parkinson disease, Crohn disease, multiple sclerosis, immune disorders, fungal infections, bacterial infections, nausea, vomiting, appetite loss, small intestine disorders, diabetes, high blood sugar, cancer and side effects from the treatment of cancer, Huntington disease, symptoms of withdrawal, temporomandibular disorders, insomnia, trouble sleeping, anxiety, depression, schizophrenia, and bipolar disorder
First Use Anywhere:
20200300
First Use in Commerce:
20200300
Classification
International Classes
001